Pasquale Agosti, MD, PhD

Università degli Studi di Milano, Department of Pathophysiology and Transplantation and Fondazione Luigi Villa, Milan, Italy
Milano, Lombardia, Italy

Pasquale Agosti (MD, PhD), Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, and Fondazione Luigi Villa, Milan, Italy.
Following my graduation in medicine and specialization in geriatrics at the university medical school in Bari, I started the PhD program in Traslational Medicine at the University of Milan. Under the supervision of Professor Flora Peyvandi, I acquired an in-depth scientific knowledge in the field of hemostasis and thrombosis, in particular in thrombotic microangiopathies, congenital bleeding disorders and thrombosis, and skills in the methodology of clinical and translational research. I am currently an Assistant Professor at the University of Milan.

Presentation(s):

• OC 24.3 - Minimum Baseline FVIII Levels Required to Prevent Joint Bleeding Episodes: a Study in Mild Hemophilia A

  Sunday, June 25, 2023
  15:15 – 15:30 ET

• OC 26.3 - Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura

  Sunday, June 25, 2023
  15:15 – 15:30 ET

• PB0027 - Assessing genetic risk factors for early-onset coronary artery disease in Iranians

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0316 - Bortezomib for the treatment of multi-refractory immune-mediated thrombotic thrombocytopenic purpura: an Italian multicenter survey

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0321 - Prospective evaluation of the HemosIL AcuStar ADAMTS13 Activity Assay

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0333 - Therapeutic Plasma Exchange-Related Complications in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 42.2 - Incidence and Risk Factors of Major Adverse Cardiovascular Events in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura During Remission

  Monday, June 26, 2023
  15:00 – 15:15 ET

• OC 42.3 - Immune-mediated TTP patients in remission with recovered ADAMTS13 activity but an open ADAMTS13 conformation are at risk for earlier ADAMTS13 relapse

  Monday, June 26, 2023
  15:15 – 15:30 ET

• PB0640 - Safety and Efficacy of Combined Dual Antiplatelet Therapy and FVIII Prophylaxis in Hemophilia A Patients after the Acute Coronary Syndrome

  Monday, June 26, 2023
  18:30 – 19:30 ET